ClinicalTrials.gg
Not yet recruitingNCT07860424WIAUpdated Oct 6, 2026

Women in Action: A Multicomponent Intervention for Older Women

An interventional study of Multicomponent exercise, nutrition, and psychoeducational program in Sarcopenia, Physical Inactivity and Menopause, sponsored by Universidad de Oviedo. Not yet recruiting at 2 sites in Spain. Open to female participants aged 55 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Universidad de Oviedo · Not applicable, Interventional, and Other

How we know

Updated Oct 6, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
214
Allocation
Non-randomized
Ages
55 Years to 75 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 99 studies in Sarcopenia with a site in Spain — 33 open to participants now, 40 under way, none of them phase 3. Sarcopenia · Spain.

Planned enrollment
11th of 77
214 · median 72
Started
2026
with 15 others
No phase
70 of 99
26 open now
Primary completion
2027-12
later than 34 of 39 live
Registered
95th of 99
by date

Among the 99 studies in Sarcopenia with a site in Spain, this one is the 11th largest by planned enrollment of the 77 interventional ones that give a count, is one of 16 that started in 2026, is one of 70 with no phase, reaches primary completion later than 34 of the 39 other live ones, and was the 95th registered.

Sarcopenia

1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.

Browse Sarcopenia studies →

Open to participants now

33 of the 99 studies in Sarcopenia with a site in Spain are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.

This study: 55 Years to 75 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 99 studies in Sarcopenia with a site in Spain, or all of them as a file.
02

Study summary

"Women in Action" is a quasi-experimental, mixed-methods study evaluating a 16-week multicomponent intervention (supervised strength/aerobic/balance training plus psychoeducational and nutrition-focused behavioral workshops) for women aged 55-75 in perimenopause, menopause, and early ageing. The study will assess the feasibility, implementation fidelity, and acceptability of the program, together with its preliminary effects on a single primary outcome (handgrip strength) and secondary physical function, dietary, and psychosocial outcomes, compared with a passive control group receiving no intervention.

Read the detailed description

Participants will be allocated to an Intervention or Control group using a non-random, minimization-based procedure balancing key baseline characteristics (age, menopausal status, physical activity level, physical function, gender-related stereotype internalization, socioeconomic status, geographical context). The Intervention group receives supervised strength, aerobic, and balance training (2 sessions/week, 50-60 min, 16 weeks) plus 8 biweekly psychoeducational and nutrition-focused workshops (90 min each). Assessments occur at baseline (T0), mid-intervention (T1, week 8), post-intervention (T2, week 16), and 3-month follow-up (T3). The primary outcome is handgrip strength (T0 to T2 change). Secondary outcomes include the Short Physical Performance Battery, body composition (bioelectrical impedance analysis), Mediterranean diet adherence (MEDAS), a 3-day dietary record (energy and protein intake), and validated psychosocial instruments (personal agency/empowerment, physical self-concept, ageing- and exercise-related stereotypes, exercise self-efficacy). A qualitative strand (focus groups at T2 and T3) is integrated using a convergent parallel mixed-methods design. The primary analysis will use linear mixed-effects models under an intention-to-treat framework.

03

Conditions studied

  • Sarcopenia
  • Physical Inactivity
  • Menopause
  • Healthy Aging

Keywords

  • gender stereotypes
  • personal agency
  • strength training
  • Mediterranean diet
  • healthy ageing, physical function
  • older women
  • health behavior
  • community-based intervention
04

Who can participate

Ages eligible
55 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 55-75 years
  • Residing in the Principality of Asturias, Spain
  • Written
  • Medical clearance for supervised moderate-to-vigorous physical activity
  • Suboptimal physical activity level (not meeting WHO recommendations of ≥150 min/week moderate or ≥75 min/week vigorous aerobic activity and/or \<2 muscle-strengthening sessions/week, and/or low adherence to prior exercise routines), screened via the Global Physical Activity Questionnaire (GPAQ)
  • Relevant exposure to gender-related stereotypes associated with physical activity
  • Willingness to complete all assessment phases (T0-T3)

Exclusion criteria

Exclusion Criteria:

  • Medical conditions contraindicating supervised exercise
  • Severe cognitive impairment limiting program participation
  • Concurrent involvement in structured resistance-training interventions
  • Any physical or functional condition precluding safe execution of physical performance assessments (handgrip strength, SPPB)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
214 participants (estimated)

Study arms

  • Experimental
    Multicomponent

    Participants receive the 16-week "Women in Action" multicomponent program: supervised strength, aerobic, and balance training (2 sessions/week, 50-60 min/session) plus 8 biweekly psychoeducational and nutrition-focused behavioral workshops (90 min each; 4 nutrition-focused, 4 psychoeducational). Optional, separately consented co-educational workshops involving men are offered as an additional module.

    Behavioral: Multicomponent exercise, nutrition, and psychoeducational program

  • No intervention
    No multicomponent

    Participants maintain their usual lifestyle habits with no intervention exposure during the study period and receive basic intervention-related information after study completion.

Interventions

  • BehavioralMulticomponent exercise, nutrition, and psychoeducational program

    16-week program combining supervised resistance, aerobic, and balance training with psychoeducational and nutrition-focused behavioral workshops, delivered by qualified exercise professionals, psychologists, and nutrition professionals.

06

What researchers measure

Primary outcomes

  1. Change in Lower-Limb Strength

    Standing-up and sitting-down test (number of repetitions of standing up and sitting down from a chair in 30 seconds).

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  2. Change in Handgrip Strength

    Hand grip strength: Assessed using a manual (hand) dynamometer (kg).

    Time frame: Time Frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

Secondary outcomes

  1. Change in Body Composition (Fat, Muscle, and Bone Mass)

    Assessed via bioelectrical impedance analysis (BIA), using a validated, standardized, field-applicable device. Measures: body mass (body fat, muscle mass, and bone mass in kg)

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  2. Change in Basal Metabolic Rate

    Basal metabolic rate in kcal.

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  3. Change in Body Mass Index (BMI)

    BMI in kg/m²

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  4. Change in Mediterranean Diet Adherence Score

    Measured by the Mediterranean Diet Adherence Screener (MEDAS): score from 1 to 14. Scoring method: Some items are scored as "more than once a day" (equivalent to 1 point), and other items are scored as "three or more times a day/week" (equivalent to 1 point).

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  5. Change in Personal Agency and Empowerment Score

    Measured by the Spanish Validated Scale of Personal Agency and Empowerment (ESAGE-Sp-19). Responses are collected using a Likert-type scale. A Likert scale consisting of 19 items organized into the following factors: Personal Agency, Self-Confidence, Internal Control, and Empowerment. There are 5 response options ranging from 0 (never) to 4 (always). The total score is the arithmetic mean.

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  6. Change in Physical Self-Concept Score

    CAF-MAY score. 30-item Physical Self-Concept Questionnaire for Older Adults (CAF-MAY), which measures the subject's perception of the following dimensions of the personal self: physical ability (6 items), physical appearance (6 items), health/illness (6 items), functional ability (6 items), and general physical self-concept (6 items). The test is formatted as a Likert scale with 5 response options: strongly disagree (1) to strongly agree (5). The total score is the arithmetic mean.

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  7. Change in Ageing- and Exercise-Related Stereotypes Score

    Measured by the Ageing Stereotypes and Exercise Scale (ASES). The ASES is a self-report measure assessing stereotypes about aging in the context of exercise and physical activity. The questionnaire consists of 15 items scored on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores are obtained by summing item responses and range from 15 to 75, with higher scores indicating more positive stereotypes regarding aging and exercise (more favorable beliefs about older adults' ability to engage in and benefit from exercise) and lower scores indicating more negative stereotypes and greater perceived barriers to exercise among older adults.

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

  8. Change in Exercise Self-Efficacy Score

    Self-Efficacy for Exercise Scale, SEE score. The Self-Efficacy for Exercise Scale is a self-report measure of an individual's confidence in their ability to engage in regular exercise under a variety of challenging conditions. The scale consists of 9 items, each rated on an 11-point scale ranging from 0 (Not Confident) to 10 (Very Confident). Total scores are calculated by summing all item responses and range from 0 to 90, with higher scores indicating greater self-efficacy for exercise (better outcome) and lower scores indicating lower confidence in the ability to maintain regular exercise (worse outcome).

    Time frame: 1) baseline assessment (pre-intervention): week 0; 2) intermediate assessment: week 8; 3) post-intervention assessment: week 16; 4) follow-up evaluation (3 months after the intervention ended).

Other outcomes

  1. Change in Number of Exercise Sessions Attended

    Number of weekly exercise sessions attended by each participant out of the total sessions offered, self-reported via a Microsoft Forms questionnaire.

    Time frame: 1) intermediate assessment: week 8 and 2) post-intervention assessment: week 16; 3) follow-up evaluation (3 months after the intervention ended: Participants will be asked, via a Microsoft Forms questionnaire, how many weekly exercise session).

07

Study locations

2 sites
  • University of Oviedo, Faculty of Teacher Education and Education, Oviedo, Asturias, Spain
    Oviedo, Principality of Asturias 33005, Spain
    • Noelia Belando, PhD. · Contactbelandonoelia@uniovi.es · 620514995
    • Irene Barbero Alcocer · Sub investigator
    • Ángel Ballester Sánchez, Personal trainner · Sub investigator
    • Guillermo Peña García-Orea, PhD. · Sub investigator
  • University of Oviedo, Faculty of Teacher Education and Education, Oviedo, Asturias, Spain
    Oviedo, Principality of Asturias 33005, Spain
08

References and documents

Publications

  • Marques DL, Neiva HP, Marinho DA, Marques MC. Velocity-Monitored Resistance Training in Older Adults: The Effects of Low-Velocity Loss Threshold on Strength and Functional Capacity. J Strength Cond Res. 2022 Nov 1;36(11):3200-3208. doi: 10.1519/JSC.0000000000004036. Epub 2021 Apr 5. PubMed 34537803 ↗
  • Gonzalez-Galvez N, Moreno-Torres JM, Vaquero-Cristobal R. Resistance training effects on healthy postmenopausal women: a systematic review with meta-analysis. Climacteric. 2024 Jun;27(3):296-304. doi: 10.1080/13697137.2024.2310521. Epub 2024 Feb 14. PubMed 38353251 ↗
  • Yan R, Chen Y, Zhang R, He J, Lin W, Sun J, Li D. Optimal resistance training prescriptions to improve muscle strength, physical function, and muscle mass in older adults diagnosed with sarcopenia: a systematic review and meta-analysis. Aging Clin Exp Res. 2025 Nov 10;37(1):320. doi: 10.1007/s40520-025-03235-w. PubMed 41212331 ↗
  • Ramirez-Campillo R, Diaz D, Martinez-Salazar C, Valdes-Badilla P, Delgado-Floody P, Mendez-Rebolledo G, Canas-Jamet R, Cristi-Montero C, Garcia-Hermoso A, Celis-Morales C, Moran J, Buford TW, Rodriguez-Manas L, Alonso-Martinez AM, Izquierdo M. Effects of different doses of high-speed resistance training on physical performance and quality of life in older women: a randomized controlled trial. Clin Interv Aging. 2016 Dec 13;11:1797-1804. doi: 10.2147/CIA.S121313. eCollection 2016. PubMed 28008239 ↗
  • Streetman AE, Walden RL, Orr CJ, Heerman WJ. Exercise empowerment: a scoping review of randomized controlled trials and quasi-experimental physical activity interventions. Int J Behav Nutr Phys Act. 2025 Dec 10;23(1):5. doi: 10.1186/s12966-025-01859-9. PubMed 41366451 ↗
  • Deshayes M, Palermo A, Korchi K, Philippe AG. Influence of negative stereotype on physical activity level among older adults during a training session. Front Sports Act Living. 2022 Nov 25;4:998724. doi: 10.3389/fspor.2022.998724. eCollection 2022. PubMed 36506719 ↗
  • Yu J, Li X, Yu H, Huang Y. Comparative effectiveness of exercise modalities and nutritional supplementation for sarcopenic obesity in older adults: a network meta-analysis based on randomized controlled trials. Front Public Health. 2026 Feb 23;14:1775783. doi: 10.3389/fpubh.2026.1775783. eCollection 2026. PubMed 41810309 ↗
  • Qiu H, Zheng W, Zhou X, Liu Q, Zhao X. Training modalities for elder sarcopenic obesity: a systematic review and network meta-analysis. Front Nutr. 2025 Feb 19;12:1537291. doi: 10.3389/fnut.2025.1537291. eCollection 2025. PubMed 40046765 ↗
  • Guo C, Dai T, Zhang H, Luo M, Gao J, Feng X. Effect of resistance training on body composition and physical function in older females with sarcopenic obesity-a systematic review and meta-analysis of randomized controlled trials. Front Aging Neurosci. 2025 Apr 30;17:1495218. doi: 10.3389/fnagi.2025.1495218. eCollection 2025. PubMed 40370749 ↗
  • Courel-Ibanez J, Buendia-Romero A, Pallares JG, Garcia-Conesa S, Martinez-Cava A, Izquierdo M. Impact of Tailored Multicomponent Exercise for Preventing Weakness and Falls on Nursing Home Residents' Functional Capacity. J Am Med Dir Assoc. 2022 Jan;23(1):98-104.e3. doi: 10.1016/j.jamda.2021.05.037. Epub 2021 Jun 29. PubMed 34197791 ↗
  • Chen J, Liu H, Zhao H, Yao J, Lu Y. The effects of vivifrail-based multicomponent training on physical and cognitive function in frail older adults: a systematic review and meta-analysis. Front Physiol. 2025 Jul 29;16:1646833. doi: 10.3389/fphys.2025.1646833. eCollection 2025. PubMed 40800730 ↗
  • Chalabaev A, Emile M, Corrion K, Stephan Y, Clement-Guillotin C, Pradier C, d'Arripe-Longueville F. Development and validation of the aging stereotypes and exercise scale. J Aging Phys Act. 2013 Jul;21(3):319-34. doi: 10.1123/japa.21.3.319. Epub 2012 Oct 11. PubMed 23070895 ↗
  • Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31. doi: 10.1093/gerona/55.4.m221. PubMed 10811152 ↗
  • Sherrington C, Fairhall NJ, Wallbank GK, Tiedemann A, Michaleff ZA, Howard K, Clemson L, Hopewell S, Lamb SE. Exercise for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012424. doi: 10.1002/14651858.CD012424.pub2. PubMed 30703272 ↗
  • Wallin A, Johansson S, Brincks J, Dalgas U, Franzen E, Callesen J. Effects of Balance Exercise Interventions on Balance-Related Performance in People With Multiple Sclerosis: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials. Neurorehabil Neural Repair. 2024 Oct;38(10):775-790. doi: 10.1177/15459683241273402. Epub 2024 Aug 20. PubMed 39162296 ↗
  • Hwang CL, Yoo JK, Kim HK, Hwang MH, Handberg EM, Petersen JW, Christou DD. Novel all-extremity high-intensity interval training improves aerobic fitness, cardiac function and insulin resistance in healthy older adults. Exp Gerontol. 2016 Sep;82:112-9. doi: 10.1016/j.exger.2016.06.009. Epub 2016 Jun 21. PubMed 27346646 ↗
  • Singer A, Wolf M, Generoso L, Arias E, Delcastillo K, Echevarria E, Martinez A, Androulakis Korakakis P, Refalo MC, Swinton PA, Schoenfeld BJ. Give it a rest: a systematic review with Bayesian meta-analysis on the effect of inter-set rest interval duration on muscle hypertrophy. Front Sports Act Living. 2024 Aug 14;6:1429789. doi: 10.3389/fspor.2024.1429789. eCollection 2024. PubMed 39205815 ↗
  • Sanchez-Medina L, Gonzalez-Badillo JJ. Velocity loss as an indicator of neuromuscular fatigue during resistance training. Med Sci Sports Exerc. 2011 Sep;43(9):1725-34. doi: 10.1249/MSS.0b013e318213f880. PubMed 21311352 ↗
  • Ozemek C, Bonikowske A, Christle J, Gallo P, editors. ACSM's Guidelines for Exercise Testing and Prescription. 12th ed. Philadelphia: Wolters Kluwer; 2025.
  • Fuller T, Peters J, Pearson M, Anderson R. Impact of the transparent reporting of evaluations with nonrandomized designs reporting guideline: ten years on. Am J Public Health. 2014 Nov;104(11):e110-7. doi: 10.2105/AJPH.2014.302195. Epub 2014 Sep 11. PubMed 25211744 ↗
  • Hu C, Xia Y, Zeng D, Ye M, Mei T. Effect of resistance circuit training on comprehensive health indicators in older adults: a systematic review and meta-analysis. Sci Rep. 2024 Apr 17;14(1):8823. doi: 10.1038/s41598-024-59386-9. PubMed 38627495 ↗
  • Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, Frazee K, Dube J, Andreacci J. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003 Feb;35(2):333-41. doi: 10.1249/01.MSS.0000048831.15016.2A. PubMed 12569225 ↗
  • Pareja-Blanco F, Loturco I. Level of Effort: A Practical Approach for Resistance Training Monitoring and Prescription. J Hum Kinet. 2026 Apr 30;102:259-266. doi: 10.5114/jhk/221229. eCollection 2026 Apr. PubMed 42211812 ↗
  • Currier BS, D'Souza AC, Singh MAF, Lowisz CV, Rawson ES, Schoenfeld BJ, Smith-Ryan AE, Steen JP, Thomas GA, Triplett NT, Washington TA, Werner TJ, Phillips SM. American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Med Sci Sports Exerc. 2026 Apr 1;58(4):851-872. doi: 10.1249/MSS.0000000000003897. Epub 2026 Mar 5. PubMed 41843416 ↗
  • Zhou Y, Wen K, Zhang X, Sun Y. Effects of resistance training on muscle mass, strength, and physical function in older women with sarcopenia: a systematic review and meta-analysis. Front Public Health. 2026 Jan 26;13:1735899. doi: 10.3389/fpubh.2025.1735899. eCollection 2025. PubMed 41668861 ↗
  • Valenzuela PL, Saco-Ledo G, Morales JS, Gallardo-Gomez D, Morales-Palomo F, Lopez-Ortiz S, Rivas-Baeza B, Castillo-Garcia A, Jimenez-Pavon D, Santos-Lozano A, Del Pozo Cruz B, Lucia A. Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials. Lancet Healthy Longev. 2023 Jun;4(6):e247-e256. doi: 10.1016/S2666-7568(23)00057-0. Epub 2023 May 11. PubMed 37182530 ↗
  • Cabrolier-Molina J, Martin-Rodriguez A, Clemente-Suarez VJ. The Effects of Exercise Intervention in Older Adults With and Without Sarcopenia: A Systematic Review. Sports (Basel). 2025 May 19;13(5):152. doi: 10.3390/sports13050152. PubMed 40423288 ↗
  • Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014 Mar 7;348:g1687. doi: 10.1136/bmj.g1687. PubMed 24609605 ↗
  • Eglseer D, Traxler M, Schoufour JD, Weijs PJM, Voortman T, Boirie Y, Cruz-Jentoft AJ, Reiter L, Bauer S; SO-NUTS Consortium. Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis. Nutr Rev. 2023 Aug 10;81(9):1077-1090. doi: 10.1093/nutrit/nuad007. PubMed 36882046 ↗
  • Heymans MW, Twisk JWR. Handling missing data in clinical research. J Clin Epidemiol. 2022 Nov;151:185-188. doi: 10.1016/j.jclinepi.2022.08.016. Epub 2022 Sep 21. PubMed 36150546 ↗
  • Casas-Herrero A, Saez de Asteasu ML, Anton-Rodrigo I, Sanchez-Sanchez JL, Montero-Odasso M, Marin-Epelde I, Ramon-Espinoza F, Zambom-Ferraresi F, Petidier-Torregrosa R, Elexpuru-Estomba J, Alvarez-Bustos A, Galbete A, Martinez-Velilla N, Izquierdo M. Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):884-893. doi: 10.1002/jcsm.12925. Epub 2022 Feb 11. PubMed 35150086 ↗
  • Palombi T, Chirico A, Cazzolli B, Zacchilli M, Alessandri G, Filosa L, Borghi A, Fini C, Antoniucci C, Pistella J, Alivernini F, Baiocco R, Lucidi F. Motivation, psychological needs and physical activity in older adults: a qualitative review. Age Ageing. 2025 Jul 1;54(7):afaf180. doi: 10.1093/ageing/afaf180. PubMed 40601367 ↗
  • Navarro-Martinez R, Mafla-Espana MA, Cauli O. Mediterranean Diet Adherence in Community-Dwelling Older Adults in Spain: Social Determinants Related to the Family. Nutrients. 2022 Dec 2;14(23):5141. doi: 10.3390/nu14235141. PubMed 36501170 ↗
  • Sotos-Prieto M, Ortola R, Lopez-Garcia E, Rodriguez-Artalejo F, Garcia-Esquinas E. Adherence to the Mediterranean Diet and Physical Resilience in Older Adults: The Seniors-ENRICA Cohort. J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):505-512. doi: 10.1093/gerona/glaa277. PubMed 33152061 ↗
  • WHO Guidelines on Physical Activity and Sedentary Behaviour. Geneva: World Health Organization; 2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK566045/ PubMed 33369898 ↗
  • Knowlton M, Newland BL. Beyond the Barbell: Women in Strength-Based Sports and the Reshaping of Gender Norms. Sex Roles. 2024;90(11):1567-1584. doi:10.1007/s11199-024-01521-x.
  • Rua-Alonso M, Bovolini A, Costa-Brito AR, Vaz C, Marques E, Serra N, Lopes VP, Vila-Cha C. Exploring Perceived Barriers to Physical Activity among Older Adults Living in Low-Population Density Regions: Gender Differences and Associations with Activity Dimensions. Healthcare (Basel). 2023 Nov 11;11(22):2948. doi: 10.3390/healthcare11222948. PubMed 37998440 ↗
  • Schroder H, Fito M, Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Lamuela-Raventos R, Ros E, Salaverria I, Fiol M, Lapetra J, Vinyoles E, Gomez-Gracia E, Lahoz C, Serra-Majem L, Pinto X, Ruiz-Gutierrez V, Covas MI. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011 Jun;141(6):1140-5. doi: 10.3945/jn.110.135566. Epub 2011 Apr 20. PubMed 21508208 ↗
  • Vasudevan A, Ford E. Motivational Factors and Barriers Towards Initiating and Maintaining Strength Training in Women: a Systematic Review and Meta-synthesis. Prev Sci. 2022 May;23(4):674-695. doi: 10.1007/s11121-021-01328-2. Epub 2021 Nov 20. PubMed 34800250 ↗
  • Fragala MS, Cadore EL, Dorgo S, Izquierdo M, Kraemer WJ, Peterson MD, Ryan ED. Resistance Training for Older Adults: Position Statement From the National Strength and Conditioning Association. J Strength Cond Res. 2019 Aug;33(8):2019-2052. doi: 10.1519/JSC.0000000000003230. PubMed 31343601 ↗
  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. PubMed 30312372 ↗
  • Meredith SJ, Cox NJ, Ibrahim K, Higson J, McNiff J, Mitchell S, Rutherford M, Wijayendran A, Shenkin SD, Kilgour AHM, Lim SER. Factors that influence older adults' participation in physical activity: a systematic review of qualitative studies. Age Ageing. 2023 Aug 1;52(8):afad145. doi: 10.1093/ageing/afad145. PubMed 37595070 ↗
  • Moreno-Llamas A, Garcia-Mayor J, De la Cruz-Sanchez E. Gender inequality is associated with gender differences and women participation in physical activity. J Public Health (Oxf). 2022 Dec 1;44(4):e519-e526. doi: 10.1093/pubmed/fdab354. PubMed 34604911 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — If individual-level data will not be shared beyond aggregate results, consistent with GDPR-compliant handling of participant data); confirm this choice with the University of Oviedo's data protection officer before submission.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.

Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 13 months is below that.

Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2026
First posted
Oct 6, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2027
CompletionEst.
Jun 2028
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07860424
Lead sponsor
Universidad de Oviedo
Collaborators
Instituto Politécnico de Castelo Branco
Responsible party
Noelia Belando Belando (Principal investigator, Universidad de Oviedo) — Principal investigator
First posted
Oct 6, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Oct 6, 2026

Study contacts

Noelia Belando, PR (principal research)
Contact
belandonoelia@uniovi.es
620514995
Noelia Belando, PhD.
principal investigator · Universidad de Oviedo

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion